{"description":"Documents matching 'year exclusivity provides recommendations content'","count":4338,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=year+exclusivity+provides+recommendations+content&format=json&page=2","results":[{"title":"New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled \"New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers.\" This draft guidance is intended to assist applicants requesting New Clinical Investigation exclusivity (also referred to as 3-year exclusivity) for a new drug application (NDA) or NDA supplement. The guidance discusses the statutory and regulatory criteria for eligibility for 3-year exclusivity and provides recommendations on the content and format of requests for 3-year exclusivity in the form of questions and answers (Q&As). FDA intends to update this draft guidance document to include additional Q&As as appropriate.","document_number":"2026-04291","html_url":"https://www.federalregister.gov/documents/2026/03/04/2026-04291/new-clinical-investigation-exclusivity-3-year-exclusivity-for-drug-products-questions-and-answers","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-04/pdf/2026-04291.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04291.pdf?1772545524","publication_date":"2026-03-04","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"industry entitled “New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug Products: Questions and Answers.” This draft guidance is intended to assist applicants requesting New Clinical Investigation exclusivity (also referred to as 3-year exclusivity) for a new drug application (NDA) or NDA supplement. The guidance discusses the statutory and regulatory criteria for eligibility for 3-year exclusivity and provides recommendations on the content and format of requests for 3-year exclusivity in the form of questions and answers (Q&As)"},{"title":"Classification of Digital Content Transactions and Cloud Transactions","type":"Rule","abstract":"This document contains final regulations modifying the rules for classifying transactions involving computer programs, including by applying the rules to transfers of digital content. These final regulations also provide rules for the classification of cloud transactions. These rules apply for purposes of the international provisions of the Internal Revenue Code and generally affect taxpayers engaging in transactions involving digital content or cloud transactions.","document_number":"2024-31372","html_url":"https://www.federalregister.gov/documents/2025/01/14/2024-31372/classification-of-digital-content-transactions-and-cloud-transactions","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-14/pdf/2024-31372.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-31372.pdf?1736516721","publication_date":"2025-01-14","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Internal Revenue Service","name":"Internal Revenue Service","id":254,"url":"https://www.federalregister.gov/agencies/internal-revenue-service","json_url":"https://www.federalregister.gov/api/v1/agencies/254","parent_id":497,"slug":"internal-revenue-service"}],"excerpts":"characterization of these two transactions should not depend on whether the content is actually downloaded by any particular customer. \n Another comment asserted that on-demand access to digital content should not be treated differently than temporary downloads of digital content because the two transactions are functionally equivalent in that both provide temporary access to digital content. The comment observed that the decision to provide on-demand access or temporary downloads of digital content is typically driven by the nature of the technology involved"},{"title":"Disclosure and Transparency of Artificial Intelligence-Generated Content in Political Advertisements","type":"Proposed Rule","abstract":"In this document, the Federal Communications Commission (Commission or FCC) initiates a proceeding to provide greater transparency regarding the use of artificial intelligence-generated content in political advertising. Specifically, the Commission proposes to require radio and television broadcast stations; cable operators, Direct Broadcast Satellite (DBS) providers, and Satellite Digital Audio Radio Service (SDARS) licensees engaged in origination programming; and permit holders transmitting programming pursuant to section 325(c) of the Communications Act of 1934 (Act), to provide an on-air announcement for all political ads (including both candidate ads and issue ads) that contain artificial intelligence (AI)-generated content disclosing the use of such content in the ad. The Commission also propose to require these licensees and regulatees to include a notice in their online political files for all political ads that include AI-generated content disclosing that the ad contains such content.","document_number":"2024-16977","html_url":"https://www.federalregister.gov/documents/2024/08/05/2024-16977/disclosure-and-transparency-of-artificial-intelligence-generated-content-in-political-advertisements","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-08-05/pdf/2024-16977.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-16977.pdf?1722602712","publication_date":"2024-08-05","agencies":[{"raw_name":"FEDERAL COMMUNICATIONS COMMISSION","name":"Federal Communications Commission","id":161,"url":"https://www.federalregister.gov/agencies/federal-communications-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/161","parent_id":null,"slug":"federal-communications-commission"}],"excerpts":"the Commission initiates the NPRM to provide greater transparency regarding the use of AI-generated content in political advertising. Specifically, the Commission proposes to require radio and television broadcast stations; cable operators, DBS providers, and SDARS licensees engaged in origination programming; and permit holders transmitting programming pursuant to section 325(c) of the Act, to provide an on-air announcement for all political ads that include AI-generated content disclosing the use of such content in the ad. The Commission also proposes"},{"title":"Product-Specific Guidance on Iron Sucrose; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry entitled \"Draft Guidance on Iron Sucrose.\" This revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for iron sucrose intravenous injectable.","document_number":"2025-15082","html_url":"https://www.federalregister.gov/documents/2025/08/08/2025-15082/product-specific-guidance-on-iron-sucrose-draft-guidance-for-industry-availability","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-08/pdf/2025-15082.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-15082.pdf?1754570718","publication_date":"2025-08-08","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"of NDA 205109 VELPHORO, submitted a citizen petition requesting, among other things, that FDA grant five-year new chemical entity exclusivity pursuant to sections 505(j)(5)(F)(ii) and 505(c)(3)(E)(ii) of the Federal Food, Drug, and Cosmetic Act to VELPHORO and stay the acceptance, receipt, filing, review, and/or approval of any ANDAs or 505(b)(2) applications referencing VELPHORO while FDA considers VELPHORO's new chemical entity exclusivity (Docket No. FDA-2016-P-1163, available at \n https://www.regulations.gov \n ). On May 26, 2021, FDA issued"},{"title":"Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027","type":"Proposed Rule","abstract":"This rule proposes changes and updates to the policies and payment rates used under the Skilled Nursing Facility (SNF) Prospective Payment System (PPS) for fiscal year 2027. This proposed rule also updates the requirements for the SNF Quality Reporting Program and the SNF Value-Based Purchasing Program.","document_number":"2026-06674","html_url":"https://www.federalregister.gov/documents/2026/04/07/2026-06674/medicare-program-prospective-payment-system-and-consolidated-billing-for-skilled-nursing-facilities","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-07/pdf/2026-06674.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06674.pdf?1775164507","publication_date":"2026-04-07","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"lists the measures that have been adopted for the SNF VBP Program, along with their status in the program for the FY 2027 program year through the FY 2030 program year. \n \n Table 15—SNF VBP Program Measures and Status in the SNF VBP Program for the FY 2027 Program Year Through the FY 2030 Program Year \n \n Measure \n \n FY 2027\n program year \n \n \n FY 2028\n program year \n \n \n FY 2029\n program year \n \n \n FY 2030\n program year \n \n \n \n Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) \n Included \n \n \n \n \n \n Skilled Nursing Facility H"},{"title":"Adoption of Recommendations","type":"Notice","abstract":"The Assembly of the Administrative Conference of the United States adopted four recommendations at its hybrid (virtual and in- person) Eighty-first Plenary Session: Choice of Forum for Judicial Review of Agency Rules, Individualized Guidance, Senate-Confirmed Officials and Administrative Adjudication, and Managing Congressional Constituent Service Inquiries.","document_number":"2024-14981","html_url":"https://www.federalregister.gov/documents/2024/07/09/2024-14981/adoption-of-recommendations","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-09/pdf/2024-14981.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-14981.pdf?1720442726","publication_date":"2024-07-09","agencies":[{"raw_name":"ADMINISTRATIVE CONFERENCE OF THE UNITED STATES","name":"Administrative Conference of the United States","id":566,"url":"https://www.federalregister.gov/agencies/administrative-conference-of-the-united-states","json_url":"https://www.federalregister.gov/api/v1/agencies/566","parent_id":null,"slug":"administrative-conference-of-the-united-states"}],"excerpts":"bylaws, were filed by various ACUS members regarding Recommendation 2024-3, \n Senate-Confirmed Officials and Administrative Adjudication. \n \n \n Recommendation 2024-1, \n Choice of Forum for Judicial Review of Agency Rules. \n This recommendation provides that, when drafting a statute that provides for judicial review of agency rules, Congress ordinarily should provide that rules promulgated using notice-and-comment procedures are subject to direct review by a court of appeals. The recommendation also identifies common statutory ambiguities that Congress"},{"title":"Reauthorization of the Over-The-Counter Monograph Drug User Fee Program; Public Meeting; Request for Comments","type":"Notice","abstract":"The Food and Drug Administration (FDA, the Agency, or we) is hosting a public meeting to discuss proposed recommendations for the reauthorization of the Over-The-Counter [OTC] Monograph Drug User Fee Program (OMUFA) for fiscal years (FYs) 2026 through 2030. Under OMUFA, FDA collects user fees to support OTC monograph drug activities. The current legislative authority for OMUFA expires September 30, 2025. At that time, new legislation will be required to reauthorize OMUFA for future fiscal years. Following negotiations with the regulated industry and consultation with interested members of the public, the Federal Food, Drug, and Cosmetic Act (FD&C Act) directs FDA to publish recommendations for the reauthorization of the OMUFA program in the Federal Register, provide for a period of 30 days for the public to provide written comments on such recommendations, and hold a meeting at which the public may present its views on such recommendations. FDA will then consider such public views and comments and revise such recommendations as necessary.","document_number":"2024-25458","html_url":"https://www.federalregister.gov/documents/2024/11/01/2024-25458/reauthorization-of-the-over-the-counter-monograph-drug-user-fee-program-public-meeting-request-for","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-11-01/pdf/2024-25458.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-25458.pdf?1730378728","publication_date":"2024-11-01","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"public, we do the following: (1) present the recommendations to the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions, (2) publish the recommendations in the \n Federal Register \n , \n (3) provide a period of 30 days for the public to provide written comments on the recommendations, (4) hold a meeting at which the public may present its views on the recommendations, and (5) after consideration of public views and comments, revise the recommendations as necessary.\n \n \n This \n Federal Register "},{"title":"Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2026","type":"Rule","abstract":"This final rule finalizes changes and updates to the policies and payment rates used under the Skilled Nursing Facility (SNF) Prospective Payment System (PPS) for fiscal year 2026. This final rule also updates the requirements for the SNF Quality Reporting Program and the SNF Value-Based Purchasing Program.","document_number":"2025-14679","html_url":"https://www.federalregister.gov/documents/2025/08/04/2025-14679/medicare-program-prospective-payment-system-and-consolidated-billing-for-skilled-nursing-facilities","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-04/pdf/2025-14679.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14679.pdf?1753992908","publication_date":"2025-08-04","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"available for a fiscal year. \n The total amount available for value-based incentive payments for a fiscal year is at least 60 percent of the total amount of the reduction to the adjusted SNF PPS payments for that fiscal year, as estimated by CMS, and will be increased as appropriate for each fiscal year to account for the assignment of a performance score to low-volume SNFs under paragraph (d)(3) of this section. Beginning with the FY 2023 SNF VBP, the total amount available for value-based incentive payments for a fiscal year is 60 percent of the"},{"title":"Setting and Adjusting Patent Fees During Fiscal Year 2025","type":"Rule","abstract":"The United States Patent and Trademark Office (USPTO) sets or adjusts patent fees as authorized by the Leahy-Smith America Invents Act (AIA), as amended by the Study of Underrepresented Classes Chasing Engineering and Science Success Act of 2018 (SUCCESS Act). The fee adjustments are needed to provide the USPTO with sufficient aggregate revenue to recover the aggregate estimated costs of patent operations in future years (based on assumptions and estimates found in the agency's Fiscal Year 2025 Congressional Justification (FY 2025 Budget)), including implementing the USPTO 2022-2026 Strategic Plan (Strategic Plan).","document_number":"2024-26821","html_url":"https://www.federalregister.gov/documents/2024/11/20/2024-26821/setting-and-adjusting-patent-fees-during-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-11-20/pdf/2024-26821.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-26821.pdf?1732023917","publication_date":"2024-11-20","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Patent and Trademark Office","name":"Patent and Trademark Office","id":402,"url":"https://www.federalregister.gov/agencies/patent-and-trademark-office","json_url":"https://www.federalregister.gov/api/v1/agencies/402","parent_id":54,"slug":"patent-and-trademark-office"}],"excerpts":"impact current year fee collections. Fewer patent application filings mean the USPTO collects fewer fees to devote to production-related costs in the current pipeline. The production output in one- year impacts outyear revenue because less output in one year leads to fewer issue and maintenance fee payments in future years. \n The USPTO's five-year estimated aggregate patent fee revenue (see table 3) is based on the number of patent applications it expects to receive for a given fiscal year, work it expects to process in a given fiscal year (an indicator"},{"title":"Inspection, Repair and Maintenance; Inspector Qualifications; Application for an Exemption From the American Trucking Associations","type":"Notice","abstract":"FMCSA grants a limited 5-year exemption to the American Trucking Associations (ATA) on behalf of motor carriers, intermodal equipment providers (IEPs), and individuals, from the requirements that an individual must complete 1 year of training, experience, or a combination thereof prior to being qualified to conduct annual commercial motor vehicle (CMV) inspections and to conduct brake-related inspection, repair and maintenance tasks on CMVs. The exemption covers individuals who successfully complete a training program that is self- certified by the training provider as consistent with a set of recommended practices (RPs) developed by the ATA's Technology and Maintenance Council (TMC) and motor carriers and IEPs who rely on these training programs and individuals to satisfy FMCSA's rules. The Agency has determined that granting the exemption from the requirements for 1 year of training, experience, or a combination thereof for individuals who successfully complete, and educators who provide, a performance- based inspector training program consistent with the TMC RPs, would likely achieve a level of safety equivalent to or greater than the level of safety provided by the regulatory requirements.","document_number":"2025-00898","html_url":"https://www.federalregister.gov/documents/2025/01/16/2025-00898/inspection-repair-and-maintenance-inspector-qualifications-application-for-an-exemption-from-the","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-16/pdf/2025-00898.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-00898.pdf?1736948737","publication_date":"2025-01-16","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Motor Carrier Safety Administration","name":"Federal Motor Carrier Safety Administration","id":181,"url":"https://www.federalregister.gov/agencies/federal-motor-carrier-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/181","parent_id":492,"slug":"federal-motor-carrier-safety-administration"}],"excerpts":"Corrosion Control, and Offboard Data Systems. Generally, each RP includes: \n \n • \n Preface: \n This section provides important warnings and disclaimers to the user.\n \n \n • \n Scope and Purpose: \n This section defines the purpose and scope of the RP and identifies the intended audience.\n \n \n • \n Background: \n This section provides an explanation of the need for the RP and a brief overview of the content.\n \n \n • \n Recommended Practices: \n This section provides the step-by-step guidance and procedures for addressing the issue.\n \n \n • \n References: \n This section"},{"title":"Freedom of Information Act Implementing Regulations","type":"Rule","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is amending its regulations that implement the Freedom of Information Act (FOIA) to provide clarity, promote agency accountability, improve efficiency in responding to FOIA requests, update roles and responsibilities, and align the regulations with current Federal best practices for implementing FOIA. This final rule addresses the Department of Justice (DOJ) recommendation that the NRC update its FOIA regulations and incorporate the DOJ's model language for FOIA regulations, where appropriate. The NRC is not soliciting public comment for these changes because the change is limited to an agency rule of procedure and practice.","document_number":"2026-04475","html_url":"https://www.federalregister.gov/documents/2026/03/06/2026-04475/freedom-of-information-act-implementing-regulations","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-06/pdf/2026-04475.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04475.pdf?1772718318","publication_date":"2026-03-06","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"simplifies and clarifies the method of identifying timeline requirements. \n Section 9.27—Responses to Requests \n This final rule renames § 9.27 from “Form and content of responses” to “Responses to requests.” It revises this section to align with statutory language by making clarifying changes and re-organizing content. This final rule revises this section to add: (1) details to the requirements for content of denials that includes an estimate of the volume of records withheld, (2) a description of the appeal requirements, and (3) additional information on"},{"title":"Gross Proceeds Reporting by Brokers That Regularly Provide Services Effectuating Digital Asset Sales","type":"Rule","abstract":"This document contains final regulations regarding information reporting by brokers that regularly provide services effectuating certain digital asset sales and exchanges. The final regulations require these brokers to file information returns and furnish payee statements reporting gross proceeds on dispositions of digital assets effected for customers in certain sale or exchange transactions.","document_number":"2024-30496","html_url":"https://www.federalregister.gov/documents/2024/12/30/2024-30496/gross-proceeds-reporting-by-brokers-that-regularly-provide-services-effectuating-digital-asset-sales","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-30/pdf/2024-30496.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-30496.pdf?1735307119","publication_date":"2024-12-30","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Internal Revenue Service","name":"Internal Revenue Service","id":254,"url":"https://www.federalregister.gov/agencies/internal-revenue-service","json_url":"https://www.federalregister.gov/api/v1/agencies/254","parent_id":497,"slug":"internal-revenue-service"}],"excerpts":"the core functions of the application layer is to provide DeFi protocols that users can interact with to trade digital assets. DeFi protocols provide a function that is analogous to the function provided by a stock exchange or other trading center for matching buy and sell orders in the securities industry, although there are technological differences as to how that function is carried out. \n \n A DeFi protocol is comprised of computer software that utilizes distributed ledger technology to provide digital asset exchange services through automatically"},{"title":"Air Plan Approval; Missouri; Attainment Plan for the New Madrid Nonattainment Area for the 2010 1-Hour Sulfur Dioxide National Ambient Air Quality Standard","type":"Proposed Rule","abstract":"The Environmental Protection Agency (EPA) is proposing to approve the State Implementation Plan (SIP) revision, submitted by the State of Missouri, on May 3, 2023. This revision pertains to the attainment plan for the New Madrid nonattainment area for the 2010 1- hour sulfur dioxide (SO2) primary National Ambient Air Quality Standard (NAAQS). This plan (herein called an \"attainment plan\") includes the State's attainment demonstration and other elements required under Clean Air Act (CAA). In addition to an attainment demonstration, the plan addresses emission limitations necessary to provide for attainment, base-year and projection-year emission inventories, reasonably available control measures and reasonably available control technology (RACM/RACT), nonattainment new source review (NNSR), the requirements for meeting reasonable further progress (RFP) toward attainment of the NAAQS, and contingency measures. The EPA is proposing to approve Missouri's submission as meeting these relevant CAA requirements. This action is being taken pursuant to the CAA.","document_number":"2026-09054","html_url":"https://www.federalregister.gov/documents/2026/05/07/2026-09054/air-plan-approval-missouri-attainment-plan-for-the-new-madrid-nonattainment-area-for-the-2010-1-hour","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-07/pdf/2026-09054.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-09054.pdf?1778071525","publication_date":"2026-05-07","agencies":[{"raw_name":"ENVIRONMENTAL PROTECTION AGENCY","name":"Environmental Protection Agency","id":145,"url":"https://www.federalregister.gov/agencies/environmental-protection-agency","json_url":"https://www.federalregister.gov/api/v1/agencies/145","parent_id":null,"slug":"environmental-protection-agency"}],"excerpts":"attainment year for all SO\n 2 \n sources in the nonattainment area.\n \n \n The State's attainment SIP noted that, at the time, the most recent and available triennial inventory year was 2017, and the State found that it served as a suitable base year. Because the attainment date for this area is April 30, 2026, Missouri selected 2026 as the attainment year. Table 1 summarizes the 2017 base year SO\n 2 \n emissions inventory data for all emissions categories covering the entirety of New Madrid County. Table 2 summarizes the 2026 attainment year SO\n 2 \n emissions"},{"title":"Fundamental Responsibilities of Recognized Statistical Agencies and Units","type":"Rule","abstract":"Public trust in Federal statistics is essential to their value and use in informing decisions across public and private sectors. To promote public trust in the statistical agencies and units that produce Federal statistics, the Office of Management and Budget issues this final rule pursuant to Title III of the Foundations for Evidence-Based Policymaking Act of 2018 (Evidence Act) to provide direction to Recognized Statistical Agencies and Units (RSAUs) in carrying out their four fundamental responsibilities: produce and disseminate relevant and timely statistical information, conduct credible and accurate statistical activities, conduct objective statistical activities, and protect the trust of information providers by ensuring the confidentiality and exclusive statistical use of their responses. This final rule also provides direction to other Federal agencies to enable, support, and facilitate RSAUs in carrying out these four fundamental responsibilities.","document_number":"2024-23536","html_url":"https://www.federalregister.gov/documents/2024/10/11/2024-23536/fundamental-responsibilities-of-recognized-statistical-agencies-and-units","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-10-11/pdf/2024-23536.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-23536.pdf?1728564329","publication_date":"2024-10-11","agencies":[{"raw_name":"OFFICE OF MANAGEMENT AND BUDGET","name":"Management and Budget Office","id":280,"url":"https://www.federalregister.gov/agencies/management-and-budget-office","json_url":"https://www.federalregister.gov/api/v1/agencies/280","parent_id":null,"slug":"management-and-budget-office"}],"excerpts":"Evidence-Based Policymaking Act of 2018 (Evidence Act) to provide direction to Recognized Statistical Agencies and Units (RSAUs) in carrying out their four fundamental responsibilities: produce and disseminate relevant and timely statistical information, conduct credible and accurate statistical activities, conduct objective statistical activities, and protect the trust of information providers by ensuring the confidentiality and exclusive statistical use of their responses. This final rule also provides direction to other Federal agencies to enable, support"},{"title":"Medicare Program; Contract Year 2027 and Certain Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program","type":"Rule","abstract":"This final rule revises the Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), and Medicare cost plan regulations to implement changes related to Star Ratings, marketing and communications, drug coverage, enrollment processes, special needs plans, and other programmatic areas.","document_number":"2026-06600","html_url":"https://www.federalregister.gov/documents/2026/04/06/2026-06600/medicare-program-contract-year-2027-and-certain-contract-year-2026-policy-and-technical-changes-to","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-06/pdf/2026-06600.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06600.pdf?1775160908","publication_date":"2026-04-06","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"80.1.3.2 of the Manufacturer Discount Program Final Guidance, if the manufacturer provides notice of termination under section 1860D-14C(b)(4)(B)(ii) of the Act before January 31 of a calendar year, such termination will be effective as of January 1 of the succeeding calendar year. If the manufacturer provides such notice of termination on or after January 31 of a calendar year, the termination will be effective as of January 1 of the second succeeding calendar year. \n We proposed to codify these existing policies at § 423.2752(c)(2). \n (3) Post-Termination"},{"title":"Car Loan Interest Deduction","type":"Proposed Rule","abstract":"This document contains proposed regulations regarding the deduction for certain taxpayers for an amount up to $10,000 of qualified passenger vehicle loan interest. This document also contains proposed regulations regarding new information reporting requirements for certain persons who, in a trade or business, receive from any individual interest aggregating $600 or more for any calendar year on a specified passenger vehicle loan, including applicable penalties for failures to file information returns or furnish payee statements as required. The proposed regulations would affect taxpayers that may deduct qualified passenger vehicle loan interest, and also persons subject to these information reporting requirements. This document also provides notice of a public hearing on these proposed regulations.","document_number":"2025-24154","html_url":"https://www.federalregister.gov/documents/2026/01/02/2025-24154/car-loan-interest-deduction","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-02/pdf/2025-24154.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-24154.pdf?1767188710","publication_date":"2026-01-02","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Internal Revenue Service","name":"Internal Revenue Service","id":254,"url":"https://www.federalregister.gov/agencies/internal-revenue-service","json_url":"https://www.federalregister.gov/api/v1/agencies/254","parent_id":497,"slug":"internal-revenue-service"}],"excerpts":"5, Year 1, to January 5, Year 2, the interest recipient may treat the entire interest payment as received in Year 1. If a portion of the interest for which a payment received in a calendar year accrues after January 15 of the subsequent calendar year, an interest recipient must report as interest received for the current calendar year only the portion that properly accrues by the end of the current calendar year. For example, if an interest recipient receives a monthly payment that includes interest accruing for the period December 20, Year 1, through"},{"title":"Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements","type":"Proposed Rule","abstract":"This proposed rule would update the hospice wage index, payment rates, and aggregate cap amount for Fiscal Year (FY) 2027. This proposed rule also includes an analysis of Medicare non-hospice spending, including details regarding a hospice service and spending variation index (SSVI), and proposes to require that hospices provide the hospice election statement addendum to all Medicare beneficiaries at the time of hospice election. Additionally, this rule proposes conforming regulation text changes to discharge from hospice care regulations; regulation text changes to the face-to-face encounter regulations; and includes requests for information on community palliative care services; the construction of a hospice specific wage index; and the overlap between hospice and medical aid in dying (MAID). Finally, this rule proposes changes to the Hospice Quality Reporting Program.","document_number":"2026-06604","html_url":"https://www.federalregister.gov/documents/2026/04/06/2026-06604/medicare-program-fy-2027-hospice-wage-index-and-payment-rate-update-and-hospice-quality-reporting","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-06/pdf/2026-06604.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06604.pdf?1775160907","publication_date":"2026-04-06","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"“Reporting Year” (HIS or HOPE) or “Data Collection Year” (CAHPS) is based on the calendar year (CY). It is the same CY for both HIS (or HOPE) and CAHPS. If the CAHPS Data Collection year is CY 2025, then the HIS (or HOPE) reporting year is also CY 2025. \n • In the “Payment FY”, the APU is subsequently applied to FY payments based on compliance in the corresponding Reporting Year/Data Collection Year. \n \n • For the CAHPS Hospice Survey, the Reference Year is the CY before the Data Collection Year. The Reference Year applies to hospices submitting a size"},{"title":"Age Search Service Fee Structure","type":"Proposed Rule","abstract":"The Census Bureau provides an Age Search service of confidential records from the 1910 to 2020 decennial censuses and can issue an official transcript of the results to authorized individuals. With this rule, the Census Bureau is proposing to increase the fee for conducting an Age Search from $65.00 to $155.00. The Census Bureau is also proposing to increase the additional charge for expedited requests requiring search results within one day from $20.00 per case to $50.00 per case. These changes are needed to reflect the actual operating costs associated with processing an Age Search request which were last revised in 2004.","document_number":"2026-03494","html_url":"https://www.federalregister.gov/documents/2026/02/23/2026-03494/age-search-service-fee-structure","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-23/pdf/2026-03494.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-03494.pdf?1771595116","publication_date":"2026-02-23","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"Census Bureau","name":"Census Bureau","id":42,"url":"https://www.federalregister.gov/agencies/census-bureau","json_url":"https://www.federalregister.gov/api/v1/agencies/42","parent_id":54,"slug":"census-bureau"}],"excerpts":"ACTION: \n Notice of proposed rulemaking and request for comments. \n \n \n SUMMARY: \n The Census Bureau provides an Age Search service of confidential records from the 1910 to 2020 decennial censuses and can issue an official transcript of the results to authorized individuals. With this rule, the Census Bureau is proposing to increase the fee for conducting an Age Search from $65.00 to $155.00. The Census Bureau is also proposing to increase the additional charge for expedited requests requiring search results within one day from $20.00 per case to"},{"title":"Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model","type":"Rule","abstract":"This final rule will update and revise the Increasing Organ Transplant Access (IOTA) Model for Performance Year (PY) 2. This final rule also includes a technical correction to the regulatory text.","document_number":"2026-10890","html_url":"https://www.federalregister.gov/documents/2026/06/01/2026-10890/medicare-program-alternative-payment-model-updates-and-the-increasing-organ-transplant-access-iota","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-01/pdf/2026-10890.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-10890.pdf?1779999311","publication_date":"2026-06-01","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"transplant hospital per year [200 Medicare IOTA waitlist patients × 0.25 hour per review each year × $126.92 hourly wage]. We also estimate that 25 percent of beneficiaries would need to be notified of a change in waitlist status. Using the same wage assumption noted previously, this would add $1,587 in cost per hospital [50 Medicare IOTA waitlist patients requiring a notification of a change in waitlist status × 0.25 hour per notification × $126.92 hourly wage]. Total estimated hospital cost per year is $7,933 per year [$6,346 + $1,587]. Therefore"},{"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; New Animal Drugs for Minor Use and Minor Species","type":"Notice","abstract":"The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","document_number":"2026-13005","html_url":"https://www.federalregister.gov/documents/2026/06/29/2026-13005/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-29/pdf/2026-13005.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13005.pdf?1782477909","publication_date":"2026-06-29","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n 2 \n 3 \n 6 \n 20 \n 120 \n \n \n 516.129; content and format of a request for determination of eligibility for indexing \n 20 \n 2 \n 40 \n 20 \n 800 \n \n \n 516.141; information to be submitted to FDA by a requestor seeking to establish a qualified expert panel \n 20 \n 1 \n 20 \n 16 \n 320 \n \n \n 516.143; content and format of the written report of the qualified expert panel \n 20 \n 1 \n 20 \n 120 \n 2,400 \n \n \n 516.145; content and format of a request for addition to the Index \n 10 \n 1 \n 10 \n 20 \n 200 \n \n \n 516.161; content and format of a request for modification"}]}